跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TOLVAPTAN GH tolvaptan 30 mg + 90 mg tablet blister composite pack - TGA Drug Approval Details
Approvals
/
TGA
/
TOLVAPTAN GH tolvaptan 30 mg + 90 mg tablet blister composite pack
Approved
STANDARD
TOLVAPTAN GH tolvaptan 30 mg + 90 mg tablet blister composite pack
Lupin Australia Pty Limited
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
509bc17a963408cd
Company
Lupin Australia Pty Limited
Type
Standard
Approval Details
Approval Id
509bc17a963408cd
Product Name
TOLVAPTAN GH tolvaptan 30 mg + 90 mg tablet blister composite pack
Artg Id
417518
Artg Name
TOLVAPTAN GH tolvaptan 30 mg + 90 mg tablet blister composite pack
Sponsor
Lupin Australia Pty Limited
Company Detail Path
/organization/lupin-australia-pty-limited
Artg Date
2024-10-30
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
509bc17a963408cd
Type
Standard
Back to TGA Approvals